The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Accutane and pregnancy

Private Parts

Here’s how you know when a drug’s side effects are completely out of control: When the federal government requires you to place your name and personal details about your sex life in a national registry in order to purchase the drug.

Sound extreme? It is. But this is the plan that an FDA advisory panel has come up with in an effort to reduce birth defects caused by Accutane, the prescription medicine designed to treat severe acne. As for other Accutane side effects (mostly associated with emotional instability), well, with those you’re on your own.

But for anyone, young or old, who copes with the discomfort and embarrassment of serious acne, the need for a drug and all its side effects might be made completely unnecessary with a simple change in diet.

Someone to watch over you

In the e-Alert “Dying of Embarrassment” (1/15/02), I first told you about the problems associated with Accutane use. Here are some of the highlights or rather lowlights:

  • According to the FDA, between 1998 and 2000 Accutane was linked with at least 160 cases of suicide, attempted suicide, suicidal thoughts, and hospitalization – more than 50 cases a year.
  • Other side effects (listed on the web site of Roche, Accutane’s manufacturer) include depression, psychosis, acute pancreatitis, inflammatory bowel disease and vision and hearing impairment.
  • In 1990, the FDA estimated that since the drug’s introduction in 1982, there had been 11,000 to 13,000 Accutane-related abortions, and 900 to 1,100 Accutane- related birth defects.

All of these side effects are troubling, and the suicides are particularly alarming. But last week’s recommendations from the FDA advisory panel specifically address the tragic tendency of Accutane to cause severe birth defects when used by pregnant women.

In 2001, Roche began a program to help prevent birth defects associated with the drug. Under this program, all females who take Accutane are encouraged to use two forms of birth control and take regular pregnancy tests. Even though these guidelines make it very clear that Accutane users who become pregnant are putting their unborn children in grave danger, the rate of birth defects stayed about the same. In response, the FDA panel recommended that the guidelines become mandatory, and that a registry be established to list every Accutane user (male or female), along with a record of pregnancy tests and birth control use.

If the FDA decides to accept the panel’s recommendations, Big Brother will be looking over the shoulders – and in the bedrooms – of all Accutane users.

Three strikes

To say the least, the FDA is a very aggressive regulatory agency. But this plan for a registry that will record details about a patient’s sexual life is an extreme invasion of privacy, even by FDA standards. Furthermore, it’s not even necessary because it simply won’t work. Here are three | reasons why:

1) The program to prevent pregnancy among Accutane users is already in place. If users don’t follow the current program, they’re not likely to follow it when it’s mandatory, unless each female user is escorted everywhere she goes by an FDA Accutane policeman.

2) The regulations can’t possibly be monitored and enforced. During a time of budget cutbacks throughout government agencies, is the FDA really going to mount an Accutane Task Force to make sure all the pregnancy tests have been submitted and everyone is taking their birth control? And if not, what’s the alternative? Will they start arresting Accutane users when they become pregnant?

3) If you go to the Internet and search “Accutane” and “without a prescription,” you’ll get scores of responses – site after site after site – offering Accutane with no questions asked. Needless to say, these sites don’t require pregnancy tests or any assurances about birth control.

Potato pushaway

According to a dermatologist who’s also a member of the FDA advisory panel, one of the problems with Accutane is that it’s over-prescribed. The drug is intended to address only very severe cases of acne that create large cysts. Inevitably, however, many doctors prescribe the drug for relatively normal acne cases.

This is a shame, because for people who don’t have extremely aggressive acne, a change in diet will often help clear things up.

In a 2002 article published in the Archives of Dermatology, researchers at Colorado State University wrote that acne is a problem for as much as 95% of adolescents, and half of the men and women over age 25 in westernized societies, while the rates are much lower in non-westernized countries. In fact, they call the difference in the rates “astonishing.”

For many years, alternate medicine practitioners and nutritionists like Jonathan V. Wright, M.D., and Adelle Davis have known that wheat intake can prompt acne outbreaks. And recent studies confirm that acne thrives when the diet is rich in high glycemic foods. Here’s the suspected chain of events: Bread, cereal or potatoes are consumed, digestion increases glucose levels, insulin production rises and triggers hormones to secrete sebum in pores of the skin, and the sebum attracts acne-promoting bacteria.

According to many dermatologists, a wide body of anecdotal evidence supports the theory that a low-carbohydrate diet may be the best first defense against acne for patients of all ages. If you know a young friend or family member who suffers from this painful and often embarrassing problem, | let them know that there may be a safe dietary alternative to powerful drugs with dreadful side effects.

Same old same old

Once again I can’t help but note that if an herbal supplement were associated with the level of problems that Accutane is, we would hear nothing but long howls of indignation that such a product is available to minors, let alone frequently prescribed to them. And it would be followed by a mob of congressmen demanding its immediate removal from the market, which would probably still be preferable to them monitoring the activity in your bedroom.

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:

“Panel Urges Stricter Limits on Acne Drug” Lisa Richwine, Reuters Health, reutershealth.com, 3/1/04

“Panel Backs National Accutane Registry” Lauran Neergaard, Associated Press, 2/27/04, aberdeennews.com

“FDA Announces Changes to the Risk Management Program to Prevent Birth Defects Caused by Accutane” FDA Talk Paper, 10/31/01, fda.gov

“Bread May Be the Culprit Behind Acne” Dr. Joseph Mercola, 12/25/02, mercola.com

“Acne Vulgaris: A Disease of Western Civilization” Archives of Dermatology, Vol. 138, No. 12, December 2002, archderm.ama-assn.org

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.